Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial

Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial

Introduction: COVID-19 is associated with a cascade of inflammatory responses potentially lead to devastating outcomes. Objectives: The current study aims to investigate the efficacy of montelukast, a leukotriene receptor antagonist (LTRA), on laboratory parameters in COVID-19 infection. Patients an...

Full description

Saved in:
Bibliographic Details
Main Authors: Morteza Pourahmad, Amir Aria, Mahnaz Momenzadeh, Fatemeh Nikoukar, Behrooz Ataei, Farzin Khorvash, Manizhe Shams, Kiana Shahzamani, Sara Nasirharandi
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2024-06-01
Series:Journal of Nephropharmacology
Subjects:
covid-19
leukotriene
montelukast
viral infection
Online Access:https://jnephropharmacology.com/PDF/npj-13-e11650.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jnephropharmacology.com/PDF/npj-13-e11650.pdf

Similar Items